ELIZABETH ZONA: Open Payments
NPI 1326231564 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 25 payments from 13 companies in 2025. Trend: 2023 $419 · 2024 $728 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Ardelyx, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $52 |
| Indivior Inc. | 1 | $38 |
| Braeburn Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
Products named: TREMFYA, EOHILIA, DUPIXENT, IBSRELA, VOQUEZNA, SUBLOCADE, ENTYVIO, BRIXADI.
Industry payments across PA — which companies pay providers there.
